Novel lipid signaling pathways in Alzheimer's disease pathogenesis

Biochemical Pharmacology

Volumn 88, Issue 4, 2014, Pages 560-564

  Giannopoulos, Phillip F ^a   Joshi, Yash B ^a   Praticò, Domenico ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

5 Lipoxygenase; Alzheimer's disease; Amyloid beta; Memory assessment; Synapse; Tau protein

Indexed keywords

AMYLOID BETA PROTEIN; ARACHIDONATE 5 LIPOXYGENASE; ARACHIDONIC ACID; CYCLIN DEPENDENT KINASE 5; EPITOPE; GAMMA SECRETASE; LIPID; TAU PROTEIN;

ALZHEIMER DISEASE; AMNESIA; AMYLOID PLAQUE; ENZYME MECHANISM; HUMAN; IN VITRO STUDY; LEARNING; MEMORY; NERVOUS SYSTEM INFLAMMATION; NEUROBIOLOGY; NEUROFIBRILLARY TANGLE; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN METABOLISM; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; SYNAPSE; UPREGULATION;

5-LIPOXYGENASE; ALZHEIMER'S DISEASE; AMYLOID BETA; MEMORY ASSESSMENT; SYNAPSE; TAU PROTEIN;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ARACHIDONATE 5-LIPOXYGENASE; HUMANS; LIPID METABOLISM; MEMORY DISORDERS; SIGNAL TRANSDUCTION; SYNAPSES; TAU PROTEINS;

EID: 84897954090     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2013.11.005     Document Type: Review

References (32)

1. C.W. Wong, V. Quaranta, and G.G. Glenner Neuritic plaques and cerebrovascular amyloid in Alzheimer disease are antigenically related Proc Natl Acad Sci U S A 82 1984 8729 8732
2. K.S. Kosik, C.L. Joachim, and D.J. Selkoe Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease Proc Natl Acad Sci U S A 83 1986 4044 4048 (Pubitemid 16062419)
3. W. Thies, L. Bleiler Alzheimer's Association 2013 Alzheimer's disease facts and figures Alzheimers Dement 9 2013 208 245
4. O. Radmark, and B. Samuelsson Regulation of the activity of 5-lipoxygenase, a key enzyme in leukotriene biosynthesis Biochem Biophys Res Commun 396 2010 105 110
5. C. Pergola, and O. Werz 5-Lipoxygenase inhibitors: a review of recent developments and patents Expert Opin Ther Pat 2010 355 375
6. T. Miyamoto, J.A. Lindgren, T. Hokfelt, and B. Samuelsson Regional distribution of leukotriene and mono-hydroxyeicosatetraenoic acid production in the rat brain. Highest leukotriene C4 formation in the hypothalamus FEBS Lett 216 1987 123 127
7. J.A. Lindgren, T. Hokfelt, S.E. Dahlen, C. Patrono, and B. Samuelsson Leukotrienes in the rat central nervous system Proc Natl Acad Sci U S A 81 1984 6212 6216 (Pubitemid 15220810)
8. C.M. Chinnici, Y. Yao, and D. Praticò The 5-lipoxygenase enzymatic pathway in the mouse brain: young versus old Neurobiol Aging 28 2007 1457 1462 (Pubitemid 47081230)
9. T. Qu, R. Manev, and H. Manev 5-lipoxygenase (5-LOX) promotor polymorphism in patients with early-onset and late-onset Alzheimer's disease J Neuropsychiatr Clin Neurosci 13 2001 304 305 (Pubitemid 32499684)
10. O. Firuzi, J. Zhou, C.M. Chinnici, T. Wisniewski, and D. Praticò 5-Lipoxygenase gene disruption reduces amyloid-beta pathology in a mouse model of Alzheimer's disease FASEB J 22 2008 1169 1178 (Pubitemid 351519971)
11. M.D. Ikonomovic, E.E. Abrahamson, T. Uz, H. Manev, and S.T. Dekovsky Increased 5-lipoxygenase immunoreactivity in the hippocampus of patients with Alzheimer's disease J Histochem Cytochem 56 2008 1065 1073
12. A. Di Francesco, B. Arosio, C. Gussago, E. Dainese, D. Mari, and C. D'Addario et al. Involvement of 5-lipoxygenase in Alzheimer's disease: a role for DNA methylation J. Alzheimers Dis 37 2013 3 8
13. W.T. Kimberly, M.J. LaVoie, B.L. Ostaszewski, W. Ye, M.S. Wolfe, and D.J. Selkoe Gamma-secretase is a membrane protein complex comprised of presenilin, nicastrin, Aph-1, and Pen-2 Proc Natl Acad Sci U S A 100 2003 6382 6387 (Pubitemid 36666590)
14. L. Mucke, and D.J. Selkoe Neurotoxicity of amyloid beta-protein: synaptic and network dysfunction Cold Spring Harb Prespect Med 2 2012 a006338
15. L. Bertram, C.M. Lill, and R.E. Tanzi The genetics of Alzheimer disease: back to the future Neuron 68 2010 270 281
16. J. Chu, and D. Praticò Pharmacologic blockade of 5-lipoxygenase improves the amyloidotic phenotype of an Alzheimer's disease transgenic mouse model: involvement of gamma-secretase Am J Pathol 178 2011 1762 1769
17. C.A. Hawkes, J.E. Shaw, M. Brown, A.P. Sampson, J. McLaurin, and R.O. Carare Mk886 reduces cerebral amyloid angiopathy severity in TgCRND8 mice Neurodegener Dis 2013 [Epub ahead of print]
18. J. Chu, and D. Praticò 5-Lipoxygenase as an endogenous modulator of amyloid beta in vivo Ann Neurol 69 2011 34 46
19. J. Chu, P.F. Giannopoulos, C. Ceballos-Diaz, T.E. Gold, and D. Praticò Adeno-associated virus-mediated brain delivery of 5-lipoxygenase modulates the AD-like phenotype of APP mice Mol Neurodegener 7 2012 1 10.1186/1750-1326-7-1
20. K. Sambamurti, R. Kinsey, B. Maloney, Y.W. Ge, and D.K. Lahiri Gene structure and organization of the human beta-secretase (BACE) promotor FASEB J 18 9 2004 1034 1036 (Pubitemid 39561516)
21. R.S. Doody, R. Raman, M. Farlow, T. Iwatsubo, B. Vellas, and S. Joffe et al. A phase 3 trial of semagacestat for treatment of Alzheimer's disease New Engl J Med 369 2013 341 350
22. M.S. Wolfe Inhibition and modulation of gamma-secretase for Alzheimer's disease Neurotherapeutics 5 2008 391 398 (Pubitemid 351952492)
23. L. Martin, X. Latypova, C.M. Wilson, A. Magnaudeix, M.L. Perrin, and C. Yardin et al. Tau protein kinases: involvement in Alzheimer's disease Ageing Res Rev 12 2013 289 309
24. L. Martin, X. Latypova, C.M. Wilson, A. Magnaudeix, M.L. Perrin, and C. Yardin et al. Tau protein phosphatases in Alzheimer's disease: the leading role of PP2A Ageing Res Rev 12 2013 39 49
25. F. Plattner, M. Angelo, and K.P. Giese The roles of cyclin-dependent kinase 5 and glycogen synthase kinase 3 in tau hyperphosphorylation J Biol Chem 281 35 2006 25457 25465 (Pubitemid 44401934)
26. J. Chu, and D. Praticò 5-lipoxygenase pharmacological blockade decreases tau phosphorylation in vivo: involvement of the cyclin-dependent kinase-5 Neurobiol Aging 34 2013 1549 1554
27. J. Chu, G. Li, C. Ceballos-Diaz, T. Golde, and D. Praticò The influence of 5-lipoxygenase on Alzheimer's disease-related tau pathology: in vivo and in vitro evidence Biol Psychiatry 74 5 2013 321 328
28. S. Oddo, A. Caccamo, J.D. Shepherd, M.P. Murphy, T.E. Gold, and R. Kayed et al. Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction Neuron 39 2003 409 421 (Pubitemid 36937044)
29. P.F. Giannopoulos, J. Chu, Y.B. Joshi, M. Sperow, G. Li, and L.G. Kirby et al. Gene knockout of 5-lipoxygenase rescues synaptic dysfunction and improves memory in the triple-transgenic model of Alzheimer's disease Mol Psychiatry 12 2013 10.1038/mp.2013.23
30. J. Chu, J.G. Li, and D. Praticò Zileuton improves memory deficits, amyloid and tau pathology in a mouse model of Alzheimer's disease with plaques and tangles PLoS ONE 8 2013 e70991
31. J. Chu, P.F. Giannopoulos, C. Ceballos-Diaz, T. Golde, and D. Praticò 5-Lipoxygenase gene transfer worsens memory, amyloid and tau brain pathologies in a mouse model of Alzheimer's disease Ann Neurol 72 2012 442 454
32. G.M. Shankar, S. Li, T.H. Mehta, A. Garcia-Munoz, N.E. Shepardson, and I. Smith et al. Amyloid-beta dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory Nat Med 14 2008 837 842